跳至主要内容
临床试验/JPRN-UMIN000008751
JPRN-UMIN000008751已完成未知

Multicenter study of combination therapy using calcineurin inhibitor, basiliximab, mizoribine and steroids in kidney transplantation. - Multi-drug combination therapy in kidney transplantation.

Study group on a multi-drug combination therapy for renal transplantation0 个研究点目标入组 200 人开始时间: 2012年8月31日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. The patient who has a history of hypersensitivity against components of either one of this study drugs. 2. The patient who has leucopenia. 3. The patient who is pregnant or a female patient who is expecting to become pregnant. 4. The patients who showed a positive result with cross match test. 5. The patient who recived ABO incompatible donor. 6. The patient with whom the physician-in-charge considered inappropriate as a subject of this study.

研究者

发起方
Study group on a multi-drug combination therapy for renal transplantation

相似试验